Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Geraci

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
World Journal of Diabetes|January 2, 2026
Addressing the dual challenge: Managing smoking cessation in patients with diabetesCristina Russo, Magdalena Walicka, Gal Cohen, et al.
Clinical Endocrinology|February 24, 2026
Pre-RAI Monocyte-to-Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate-Risk DTC, While PNI and NRI Show No Prognostic ValueTommaso Piticchio, Francesco Galeano, Salvatore Volpe, et al.
Life (Basel, Switzerland)|March 27, 2025
Relationship Between 8-iso-prostaglandin-F<sub>2α</sub> and Predicted 10-Year Cardiovascular Risk in Hypertensive PatientsGiulio Geraci, Alessandra Sorce, Luca Zanoli, et al.
JMIR Research Protocols|December 31, 2025
Renal Resistive Index and Cardiovascular Events, Cardiovascular Mortality, and All-Cause Mortality: Protocol for a Systematic Review and Meta-AnalysisGiulio Geraci, Vincenzo Calabrese, Pietro Ferrara, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 17, 2026
Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiographyGiulio Geraci, Pietro Ferrara, Tommaso Piticchio, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic ImplicationsGiulio Geraci, Pietro Ferrara, Luigi La Via, et al.
Cardiovascular Drugs and Therapy|May 22, 2026
Finerenone in Cardiorenal Disease: A Narrative Review of Molecular Mechanisms, Clinical Evidence, and Emerging Therapeutic RolesGiulio Geraci, Nicola Sinatra, Valentina Paternò, et al.
Journal of Endocrinological Investigation|June 1, 2026
Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction-associated steatotic liver diseaseGiulio Geraci, Valentina Paternò, Alessandro Vitello, et al.
Experimental and Therapeutic Medicine|March 26, 2019
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery diseaseGiulio Geraci, Dario Buccheri, Luca Zanoli, et al.
Aging|May 5, 2020
Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional studyCarlo Domenico Maida, Sonya Vasto, Domenico Di Raimondo, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
World Journal of Diabetes|January 2, 2026
Addressing the dual challenge: Managing smoking cessation in patients with diabetesCristina Russo, Magdalena Walicka, Gal Cohen, et al.
Clinical Endocrinology|February 24, 2026
Pre-RAI Monocyte-to-Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate-Risk DTC, While PNI and NRI Show No Prognostic ValueTommaso Piticchio, Francesco Galeano, Salvatore Volpe, et al.
Life (Basel, Switzerland)|March 27, 2025
Relationship Between 8-iso-prostaglandin-F<sub>2α</sub> and Predicted 10-Year Cardiovascular Risk in Hypertensive PatientsGiulio Geraci, Alessandra Sorce, Luca Zanoli, et al.
JMIR Research Protocols|December 31, 2025
Renal Resistive Index and Cardiovascular Events, Cardiovascular Mortality, and All-Cause Mortality: Protocol for a Systematic Review and Meta-AnalysisGiulio Geraci, Vincenzo Calabrese, Pietro Ferrara, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 17, 2026
Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiographyGiulio Geraci, Pietro Ferrara, Tommaso Piticchio, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic ImplicationsGiulio Geraci, Pietro Ferrara, Luigi La Via, et al.
Cardiovascular Drugs and Therapy|May 22, 2026
Finerenone in Cardiorenal Disease: A Narrative Review of Molecular Mechanisms, Clinical Evidence, and Emerging Therapeutic RolesGiulio Geraci, Nicola Sinatra, Valentina Paternò, et al.
Journal of Endocrinological Investigation|June 1, 2026
Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction-associated steatotic liver diseaseGiulio Geraci, Valentina Paternò, Alessandro Vitello, et al.
Experimental and Therapeutic Medicine|March 26, 2019
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery diseaseGiulio Geraci, Dario Buccheri, Luca Zanoli, et al.
Aging|May 5, 2020
Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional studyCarlo Domenico Maida, Sonya Vasto, Domenico Di Raimondo, et al.
Pageof 7